Cultured Mycobacterium tuberculosis Complex Drug Susceptibility Testing (DST) – Kanamycin in UAE | DNA Labs UAE

Executive Summary & Core Metrics

Your Trusted Diagnostic Partner for Kanamycin DST

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Secure Medical Courier Retrieval for pure isolates or VIP Temperature-Controlled Cold-Chain Home Collection for initial sputum samples (Available daily 8 AM to 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance on result interpretation from our DHA-licensed laboratory physicians.
Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This advanced phenotypic drug susceptibility test determines the resistance profile of cultured Mycobacterium tuberculosis to kanamycin, a critical second-line injectable. Results guide tailored anti-TB regimens, ensuring effective treatment and limiting the spread of multidrug-resistant tuberculosis (MDR-TB).

Feature	DNA Labs UAE	Closest Alternative
Methodology	Automated Fluorescent Detection (BACTEC MGIT 960) with phenotypic DST	Manual proportion method on Löwenstein–Jensen medium
Turnaround Time	21 working days from pure isolate	28–35 days
Sensitivity & Specificity	>98% sensitivity, 100% specificity	92–95% sensitivity

Physician Insight & Safety Protocols

As a General Practitioner overseeing infectious disease management, I emphasize that the Kanamycin DST must be interpreted within the full clinical picture, including chest imaging, sputum smear microscopy, and clinical response. A resistant result prompts alternative therapy selection, while a sensitive result must still be monitored for ototoxicity. Always consult a DHA-licensed pulmonologist before altering your regimen.

– Dr. Ajay Singh | DHA Reg: 36234132

Medication Advisory: Do Not Self-Adjust Therapy

Kanamycin is a potent second-line injectable. Self-adjusting or discontinuing prescribed anti-tubercular medication based solely on DST results can lead to treatment failure, relapse, or acquired resistance to other drugs. Always consult your prescribing physician before making any changes.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Specimen is non-viable, heavily contaminated, or not a pure growth of Mycobacterium tuberculosis complex. Hemolysed blood tubes or non-refrigerated transport.
Emergency Red Flags: If you experience suddenly worsening cough, haemoptysis (blood in sputum), pleuritic chest pain, or high fever during treatment, seek immediate emergency medical attention.

Patient FAQ & Clinical Guidance

1. What does a "Sensitive" versus "Resistant" result mean for my TB treatment?

A “Sensitive” result indicates that kanamycin remains an effective treatment option against your specific strain of tuberculosis. A “Resistant” result suggests the bacteria carry mutations (commonly in the rrs gene) that render kanamycin ineffective. Your physician will use this information to select alternative second-line drugs and construct a fully effective regimen.

2. How is the pure mycobacterial isolate obtained for this DST test?

The process begins with a sputum sample collected from you, either at home or at a collection center. The laboratory then cultures this sample to isolate a pure growth of Mycobacterium tuberculosis. It is this pure isolate that is subjected to drug susceptibility testing. No additional samples are required from you for the DST step itself.

3. What are the clinical risks of Kanamycin, and how are they monitored?

Kanamycin can cause ototoxicity (hearing loss or tinnitus) and nephrotoxicity (kidney damage). Baseline and regular audiometry (hearing tests) and renal function tests are mandatory throughout treatment. Report any ringing in the ears, hearing loss, dizziness, or changes in urination to your healthcare provider immediately.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and informed consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our testing protocols are ISO 9001:2015 certified and fully compliant with Dubai Healthcare City (DHCC) regulations.

Clinical & Logistical Metadata

Test Name	Cultured Mycobacterium tuberculosis Complex Drug Susceptibility Testing (DST) – Kanamycin
Price (AED)	650
Turnaround Time	21 working days from pure isolate receipt
Sample Type / Matrix	Pure Mycobacterial Isolate (Sputum Culture-Derived)
Methodology Used	Automated Fluorescent Detection (BACTEC MGIT 960) with Phenotypic DST
ICD-10-CM Code	A15.0, U84.30
LOINC Code	70664-3
DHA Facility License & Address	License 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE